Advertisement

Rheumatology International

, Volume 32, Issue 8, pp 2377–2382 | Cite as

A comparative analysis of serological parameters and oxidative stress in osteoarthritis and rheumatoid arthritis

  • Rachana Mishra
  • Aastha Singh
  • Vishal Chandra
  • Mahendra P. S. Negi
  • Baishnab C. Tripathy
  • Jaya Prakash
  • Varsha GuptaEmail author
Original Article

Abstract

Progression of Rheumatoid arthritis (RA) and osteoarthritis (OA) is associated with inflammation and oxidative stress. Previous studies have shown that there was no difference between RA and OA patients regarding the percentages of the different lymphocytes subsets reflecting the abnormalities in T cells and its subsets that may contribute to the pathogenesis of OA as in RA. Therefore, the present study was aimed to analyze that whether disease activity of OA is able to affect a few serological and biochemical parameters in the same way as RA does or differently. The study was done on 36 asymptomatic controls (25 women), 28 patients with OA (20 women), 36 patients with RA (22 women). Patients with OA were screened according to radiological and clinical finding of Kellgren and Lawrence grade and ACR criteria and assessed by VAS and WOMAC score. Patients with RA were selected who were fulfilling 4/5 symptoms of ACR criteria, and their DAS28-CRP, VAS score, and RF positivity were evaluated. Participants of the groups were matched for sex, age, weight, and height (body mass index). The BMI of all three groups was also found to be the same (P > 0.05). The mean level of LDL, Cholesterol, MDA, CRP, and Triglyceride was significantly (P < 0.05 or P < 0.01) higher in both OA and RA as compared to control. The mean level of total lipid, cholesterol, MDA, CRP, and triglyceride was found to be significantly (P < 0.05 or P < 0.01) higher in RA as compared to OA. The pre-treatment CRP level of both groups of patients showed significant and direct relation with total lipid (r = 0.27, P < 0.05) and cholesterol (r = 0.66, P < 0.01). Inverse relation was observed between Uric acid and Creatinine (r = −0.26, P < 0.05) and cholesterol and HDL (r = −0.34, P < 0.01). Our study shows the similar trend in lipid profile and other parameters studied in both patients with OA and patients with RA with more pronounced changes in RA.

Keywords

Osteoarthritis Rheumatoid arthritis Cardiovascular disease Dyslipedemia High density lipoprotein Low density lipoprotein Cholesterol 

Abbreviations

OA

Osteoarthritis

RA

Rheumatoid arthritis

CVD

Cardiovascular disease

HDL

High density lipoprotein

LDL

Low density lipoprotein

CRP

C-reactive protein

MDA

Malondialdehyde

Notes

Acknowledgments

The work was supported by grant of Department of Science and Technology, Govt. of India (FT/L-101/2006).

References

  1. 1.
    Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W, Cooke TD, Greenwald R, Hochberg M et al (1986) Development of criteria for the classification and reporting of osteoarthritis classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 29:1039–1049PubMedCrossRefGoogle Scholar
  2. 2.
    Arfaj AS (2003) Radiographic osteoarthritis and serum cholesterol. Saudi Med 24:745–747Google Scholar
  3. 3.
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al (1988) The American Rheumatism Association 1987 revised criteria for classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMedCrossRefGoogle Scholar
  4. 4.
    Assous N, Touzé E, Meune C, Kahan A, Allanore Y (2007) Cardiovascular disease in rheumatoid arthritis: single-center hospital-based cohort study in France. Joint Bone Spine 74:66–72PubMedCrossRefGoogle Scholar
  5. 5.
    Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW (1988) Validation study of WOMAC a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 15:1833–1840PubMedGoogle Scholar
  6. 6.
    Bellamy N, Campbell J, Stevens J, Pilch L, Stewart C, Mahmood Z (1997) Validation study of a computerized version of the Western Ontario and McMaster Universities VA3.0 osteoarthritis index. J Rheumatol 24:2413–2415PubMedGoogle Scholar
  7. 7.
    Boers M, Nurmohamed MT, Doelman CJ, Lard LR, Verhoeven AC, Voskuyl AE, Huizinga TW, van de Stadt RJ, Dijkmans BA, van der Linden S (2003) Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis. Ann Rheum Dis 62:842–845PubMedCrossRefGoogle Scholar
  8. 8.
    Bos SD, Suchiman HE, Kloppenburg M, Houwing-Duistermaat JJ, le Graverand MP, Seymour AB, Kroon HM, Slagboom PE, Meulenbelt I (2008) Allelic variation at the C-reactive protein gene associates to both hand osteoarthritis severity and serum high sensitive C-reactive protein levels in the GARP study. Ann Rheum Dis 67:877–879PubMedCrossRefGoogle Scholar
  9. 9.
    Buchanan MJ, Isdale IC, Rose BS (1965) Serum uric acid estimation chemical and enzymatic methods compared. Ann Rheum Dis 24:285–288PubMedCrossRefGoogle Scholar
  10. 10.
    Choi HK, Seeger JD (2005) Lipid profiles among US elderly with untreated rheumatoid arthritis—the Third National Health and Nutrition Examination Survey. J Rheumatol 32:2311–2316PubMedGoogle Scholar
  11. 11.
    Dahlqvist RS, Neumann-Andersen G, Backman C, Dahlen G, Stegmayr B (1997) Echocardiographic findings, lipids and lipoprotein(a) in patients with systemic lupus erythematosus. Clin Rheumatol 16:140–148CrossRefGoogle Scholar
  12. 12.
    Dursunoğlu D, Evrengül H, Polat B, Tanriverdi H, Cobankara V, Kaftan A, Kiliç M (2005) Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis: serum levels and relationship to inflammation. Rheumatol Int 25:241–245PubMedCrossRefGoogle Scholar
  13. 13.
    Firestein GS (1997) Etiology and pathogenesis of rheumatoid arthritis. In: Kelley WN, Harris ED, Ruddy S, Sledge CB (eds) Textbook of rheumatology. Saunders, Philadelphia, pp 851–897Google Scholar
  14. 14.
    Georgiadis AN, Papavasiliou EC, Lourida ES, Alamanos Y, Kostara C, Tselepis AD, Drosos AA (2006) Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment—a prospective, controlled study. Arthritis Res Ther 8:R82PubMedCrossRefGoogle Scholar
  15. 15.
    Grigolo B, Roseti L, Fiorini M, Facchini A (2003) Enhanced lipid peroxidation in synoviocytes from patients with osteoarthritis. J Rheumatol 30:345–347PubMedGoogle Scholar
  16. 16.
    Günther KP, Puhl W, Brenner H, Stürmer T (2002) Clinical epidemiology of hip and knee joint arthroses: an overview of the results of the “Ulm Osteoarthrosis Study”. Z Rheumatol 61:244–249PubMedCrossRefGoogle Scholar
  17. 17.
    Isomäki HA, Mutru O, Koota K (1975) Death rate and causes of death in patients with rheumatoid arthritis. Scand J Rheumatol 4:205–208PubMedCrossRefGoogle Scholar
  18. 18.
    Karvounaris SA, Sidiropoulos PI, Papadakis JA, Spanakis EK, Bertsias GK, Kritikos HD, Ganotakis ES, Boumpas DT (2007) Metabolic syndrome is common among middle-to-older aged Mediterranean patients with rheumatoid arthritis and correlates with disease activity: a retrospective, cross-sectional, controlled, study. Ann Rheum Dis 66:28–33PubMedCrossRefGoogle Scholar
  19. 19.
    Kellgren JH, Lawrence JS (1957) Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16:494–502PubMedCrossRefGoogle Scholar
  20. 20.
    Laurence LB (2001) In: Hardman JG, Limbird LE, Gilman AG (eds) Goodman and Gilmans: the pharmacological basis of therapeutics, 10th edn. McGraw-Hill Publishers, New YorkGoogle Scholar
  21. 21.
    Leheita O, Abed Elrazek NY, Younes S, Mahmoud AZ (2005) Lymphocytes subsets in osteoarthritis versus rheumatoid arthritis. Egypt J Immunol 12:113–124PubMedGoogle Scholar
  22. 22.
    Mutru O, Laakso M, Isomaki H, Koota K (1989) Cardiovascular mortality in patients with rheumatoid arthritis. Cardiology 76:71–77PubMedCrossRefGoogle Scholar
  23. 23.
    Special communication (2001) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). Executive summary of the third report of the National Cholesterol Education Program (NCEP). JAMA 285:2486–2497Google Scholar
  24. 24.
    Nurmohamed MT (2007) Atherogenic lipid profiles and its management in patients with rheumatoid arthritis. Vasc Health Risk Manag 3:845–852PubMedGoogle Scholar
  25. 25.
    Ohkawa H, Ohis N, Yagi K (1979) Assay of lipid peroxides in animal tissues by thiobarbituric reaction. Anal Biochem 95:351PubMedCrossRefGoogle Scholar
  26. 26.
    Panoulas VF, Douglas KM, Milionis HJ, Stavropoulos-Kalinglou A, Nightingale P, Kita MD, Tselios AL, Metsios GS, Elisaf MS, Kitas GD (2007) Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis. Rheumatology (Oxford) 46:1477–1482CrossRefGoogle Scholar
  27. 27.
    Park YB, Choi HK, Kim MY, Lee WK, Song J, Kim DK, Lee SK (2002) Effects of antirheumatic therapy on serum lipid levels in patients with rheumatoid arthritis: a prospective study. Am J Med 113:188–193PubMedCrossRefGoogle Scholar
  28. 28.
    Pawlowska J, Mikosik A, Soroczynska-Cybula M, JóŸwik A, £uczkiewicz A, Mazurkiewicz S, Lorczyñski A, Witkowski JM, Bryll E et al (2009) Different distribution of CD4 and CD8 T cells in synovial membrane and peripheral blood of rheumatoid arthritis and osteoarthritis patients. Folia Histochem Cyto Biologica 47:627–632CrossRefGoogle Scholar
  29. 29.
    Prasad K, Lee P (2003) Suppression of oxidative stress as a mechanism of reduction of hypercholesterolemic atherosclerosis by aspirin. J Cardiovasc Pharmacol Ther 8:61–69PubMedCrossRefGoogle Scholar
  30. 30.
    Sasaki JE, Krause MP, Gama MP, Hallage T, Buzzachera CF, Santos MG, Silva SG (2007) Influence of overall and abdominal adiposity on C-reactive protein levels in elderly women. Arq Bras Cardiol 89:231–236PubMedCrossRefGoogle Scholar
  31. 31.
    Sattar N, McCarey DW, Capell H, McInnes IB (2003) Explaining how “high-grade” systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 108:2957–2963PubMedCrossRefGoogle Scholar
  32. 32.
    Solomon DH, Goodson NJ, Katz JN, Weinblatt ME, Avorn J, Setoguchi S, Canning C, Schneeweiss S (2006) Patterns of cardiovascular risk in rheumatoid arthritis. Ann Rheum Dis 65:1608–1612PubMedCrossRefGoogle Scholar
  33. 33.
    Stavropoulos-Kalinoglou A, Metsios GS, Panoulas VF, Douglas KM, Nevill AM, Jamurtas AZ, Kita M, Koutedakis Y, Kitas GD (2009) Associations of obesity with modifiable risk factors for the development of cardiovascular disease in patients with rheumatoid arthritis. Ann Rheum Dis 68:242–245PubMedCrossRefGoogle Scholar
  34. 34.
    Steiner G, Urowitz MB (2009) Lipid profiles in patients with rheumatoid arthritis: mechanisms and the impact of treatment. Semin Arthritis Rheum 38:372–381PubMedCrossRefGoogle Scholar
  35. 35.
    Sun Y, Brenner H, Sauerland S, Günther KP, Puhl W, Stürmer T (2000) Serum uric acid and patterns of radiographic osteoarthritis–the Ulm osteoarthritis study. Scand J Rheumatol 29:380–386PubMedCrossRefGoogle Scholar
  36. 36.
    Tak PP, Bresnihan B (2000) The pathogenesis and prevention of joint damage in rheumatoid arthritis. Advances from synovial biopsy and tissue analysis. Arthritis Rheum 43:2619–2633PubMedCrossRefGoogle Scholar
  37. 37.
    Turesson C, Jarenros A, Jacobsson L (2004) Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study. Ann Rheum Dis 63:952–955PubMedCrossRefGoogle Scholar
  38. 38.
    Uchida K (2003) 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Prog Lipid Res 42:318–343PubMedCrossRefGoogle Scholar
  39. 39.
    Vasiliades J (1976) Reaction of alkaline sodium picrate with creatinine: I. kinetics and mechanism of formation of the mono-creatinine picric acid complex. Clin Chem 22:1664–1671PubMedGoogle Scholar
  40. 40.
    Wallberg-Jonsson S, Backman C, Johnson O, Karp K, Lundstrom E, Sundqvist KG, Rantapaa-Dahlqvist S (2001) Increased prevalence of atherosclerosis in patients with medium term rheumatoid arthritis. J Rheumatol 28:2597–2602Google Scholar
  41. 41.
    Warrington KJ, Kent PD, Frye RL, Lymp JF, Kopecky SL, Goronzy JJ et al (2005) Rheumatoid arthritis in an independent risk factor for multi-vessel coronary artery disease: a case control study. Arthritis Res Ther 7:984–991Google Scholar
  42. 42.
    Watson DJ, Rhodes T, Guess HA (2003) All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK general practice research database. J Rheumatol 30:1196–1202Google Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Rachana Mishra
    • 1
  • Aastha Singh
    • 1
  • Vishal Chandra
    • 1
  • Mahendra P. S. Negi
    • 2
  • Baishnab C. Tripathy
    • 3
  • Jaya Prakash
    • 4
  • Varsha Gupta
    • 1
    Email author
  1. 1.Department of Biotechnology, Institute of Biosciences and BiotechnologyChhatrapati Shahu Ji Maharaj UniversityKanpurIndia
  2. 2.Biometry and Statistics DivisionCentral Drug Research InstituteLucknowIndia
  3. 3.School of Life SciencesJawaharlal Nehru UniversityNew DelhiIndia
  4. 4.Vinod Dixit HospitalKannaujIndia

Personalised recommendations